TradeWell Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
TradeWell Securities's ABBV Position: Q3 2026 in Review
TradeWell Securities increased its AbbVie (ABBV) stake by 0.96% in Q3 2026, buying an estimated $24.9K and bringing the position to 10,149 shares worth $2.65M. The position accounts for 0.9% of the portfolio, ranked #17.
TradeWell Securities first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 2,025 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- TradeWell Securities held 10,149 shares of AbbVie worth $2.65M as of Q3 2026.
- TradeWell Securities bought 97 AbbVie shares in Q3 2026, an estimated $24.9K.
- AbbVie made up 0.9% of TradeWell Securities's portfolio in Q3 2026, its #17 holding.
- TradeWell Securities first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
- 2,025 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on TradeWell Securities's 13F filing for Q3 2026, filed 21 Oct 2026.